Logo image of QURE

UNIQURE NV (QURE) Stock Fundamental Analysis

USA - NASDAQ:QURE - NL0010696654 - Common Stock

30.12 USD
-0.72 (-2.33%)
Last: 11/12/2025, 8:00:01 PM
29.5 USD
-0.62 (-2.06%)
Pre-Market: 11/13/2025, 4:30:54 AM
Fundamental Rating

2

Taking everything into account, QURE scores 2 out of 10 in our fundamental rating. QURE was compared to 531 industry peers in the Biotechnology industry. Both the profitability and financial health of QURE have multiple concerns. While showing a medium growth rate, QURE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

QURE had negative earnings in the past year.
In the past year QURE has reported a negative cash flow from operations.
In the past 5 years QURE reported 4 times negative net income.
In the past 5 years QURE reported 4 times negative operating cash flow.
QURE Yearly Net Income VS EBIT VS OCF VS FCFQURE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -34.02%, QURE is in the better half of the industry, outperforming 62.71% of the companies in the same industry.
Industry RankSector Rank
ROA -34.02%
ROE N/A
ROIC N/A
ROA(3y)-32.71%
ROA(5y)-18.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QURE Yearly ROA, ROE, ROICQURE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

QURE has a Gross Margin of 82.61%. This is amongst the best in the industry. QURE outperforms 85.50% of its industry peers.
QURE's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for QURE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.17%
GM growth 5YN/A
QURE Yearly Profit, Operating, Gross MarginsQURE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

3

2. Health

2.1 Basic Checks

QURE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QURE has more shares outstanding
The number of shares outstanding for QURE has been increased compared to 5 years ago.
The debt/assets ratio for QURE is higher compared to a year ago.
QURE Yearly Shares OutstandingQURE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
QURE Yearly Total Debt VS Total AssetsQURE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

QURE has an Altman-Z score of -1.12. This is a bad value and indicates that QURE is not financially healthy and even has some risk of bankruptcy.
QURE has a Altman-Z score (-1.12) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.12
ROIC/WACCN/A
WACC6.64%
QURE Yearly LT Debt VS Equity VS FCFQURE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 9.98 indicates that QURE has no problem at all paying its short term obligations.
QURE has a Current ratio of 9.98. This is amongst the best in the industry. QURE outperforms 81.17% of its industry peers.
A Quick Ratio of 9.98 indicates that QURE has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 9.98, QURE belongs to the best of the industry, outperforming 81.36% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.98
Quick Ratio 9.98
QURE Yearly Current Assets VS Current LiabilitesQURE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

QURE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 33.57%, which is quite impressive.
Looking at the last year, QURE shows a very negative growth in Revenue. The Revenue has decreased by -48.25% in the last year.
The Revenue has been growing by 30.01% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)33.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.52%
Revenue 1Y (TTM)-48.25%
Revenue growth 3Y-62.73%
Revenue growth 5Y30.01%
Sales Q2Q%-52.71%

3.2 Future

The Earnings Per Share is expected to grow by 30.12% on average over the next years. This is a very strong growth
Based on estimates for the next years, QURE will show a very strong growth in Revenue. The Revenue will grow by 91.02% on average per year.
EPS Next Y30.16%
EPS Next 2Y17.61%
EPS Next 3Y18.96%
EPS Next 5Y30.12%
Revenue Next Year-54.34%
Revenue Next 2Y22.6%
Revenue Next 3Y77.54%
Revenue Next 5Y91.02%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QURE Yearly Revenue VS EstimatesQURE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
QURE Yearly EPS VS EstimatesQURE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 5 -5 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QURE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QURE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QURE Price Earnings VS Forward Price EarningsQURE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QURE Per share dataQURE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

QURE's earnings are expected to grow with 18.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.61%
EPS Next 3Y18.96%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QURE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UNIQURE NV

NASDAQ:QURE (11/12/2025, 8:00:01 PM)

Premarket: 29.5 -0.62 (-2.06%)

30.12

-0.72 (-2.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-25 2026-02-25/amc
Inst Owners96.08%
Inst Owner Change-3.84%
Ins Owners1.71%
Ins Owner Change0.5%
Market Cap1.86B
Revenue(TTM)14.34M
Net Income(TTM)-199.00M
Analysts85
Price Target74.27 (146.58%)
Short Float %13.12%
Short Ratio1.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)22.2%
Min EPS beat(2)20.04%
Max EPS beat(2)24.35%
EPS beat(4)3
Avg EPS beat(4)-20.97%
Min EPS beat(4)-139.62%
Max EPS beat(4)24.35%
EPS beat(8)4
Avg EPS beat(8)-24.85%
EPS beat(12)6
Avg EPS beat(12)-25.57%
EPS beat(16)9
Avg EPS beat(16)-9.21%
Revenue beat(2)0
Avg Revenue beat(2)-42.73%
Min Revenue beat(2)-75.51%
Max Revenue beat(2)-9.94%
Revenue beat(4)0
Avg Revenue beat(4)-55.95%
Min Revenue beat(4)-75.51%
Max Revenue beat(4)-9.94%
Revenue beat(8)3
Avg Revenue beat(8)-26.26%
Revenue beat(12)4
Avg Revenue beat(12)-7.79%
Revenue beat(16)5
Avg Revenue beat(16)5.86%
PT rev (1m)7.37%
PT rev (3m)108.05%
EPS NQ rev (1m)2.71%
EPS NQ rev (3m)-3.84%
EPS NY rev (1m)0.12%
EPS NY rev (3m)5.08%
Revenue NQ rev (1m)-3.24%
Revenue NQ rev (3m)6.32%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 129.41
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.94
EYN/A
EPS(NY)-3.05
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-2.82
OCFYN/A
SpS0.23
BVpS-0.06
TBVpS-1.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -34.02%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.61%
FCFM N/A
ROA(3y)-32.71%
ROA(5y)-18.82%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-30.17%
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.2%
Cap/Sales 5.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.98
Quick Ratio 9.98
Altman-Z -1.12
F-Score4
WACC6.64%
ROIC/WACCN/A
Cap/Depr(3y)98.33%
Cap/Depr(5y)124.6%
Cap/Sales(3y)24.73%
Cap/Sales(5y)20.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%40.52%
EPS Next Y30.16%
EPS Next 2Y17.61%
EPS Next 3Y18.96%
EPS Next 5Y30.12%
Revenue 1Y (TTM)-48.25%
Revenue growth 3Y-62.73%
Revenue growth 5Y30.01%
Sales Q2Q%-52.71%
Revenue Next Year-54.34%
Revenue Next 2Y22.6%
Revenue Next 3Y77.54%
Revenue Next 5Y91.02%
EBIT growth 1Y30.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.69%
EBIT Next 3Y13.84%
EBIT Next 5Y52.77%
FCF growth 1Y30.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.43%
OCF growth 3YN/A
OCF growth 5YN/A

UNIQURE NV / QURE FAQ

Can you provide the ChartMill fundamental rating for UNIQURE NV?

ChartMill assigns a fundamental rating of 2 / 10 to QURE.


Can you provide the valuation status for UNIQURE NV?

ChartMill assigns a valuation rating of 0 / 10 to UNIQURE NV (QURE). This can be considered as Overvalued.


How profitable is UNIQURE NV (QURE) stock?

UNIQURE NV (QURE) has a profitability rating of 1 / 10.


What is the earnings growth outlook for UNIQURE NV?

The Earnings per Share (EPS) of UNIQURE NV (QURE) is expected to grow by 30.16% in the next year.